Skip to main content
Accolade, Inc. (ACCD)
NASDAQ: ACCD · Real-Time Price · USD
6.93
+0.02 (0.29%)
Feb 21, 2025, 4:00 PM EST - Market closed

Accolade Revenue

Accolade had revenue of $105.06M in the quarter ending November 30, 2024, with 5.73% growth. This brings the company's revenue in the last twelve months to $446.72M, up 14.99% year-over-year. In the fiscal year ending February 29, 2024, Accolade had annual revenue of $414.29M with 14.09% growth.

Revenue (ttm)
$446.72M
Revenue Growth
+14.99%
P/S Ratio
1.21
Revenue / Employee
$186,133
Employees
2,400
Market Cap
565.39M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Feb 29, 2024414.29M51.15M14.09%
Feb 28, 2023363.14M53.12M17.13%
Feb 28, 2022310.02M139.66M81.98%
Feb 28, 2021170.36M37.85M28.57%
Feb 29, 2020132.51M37.70M39.76%
Feb 28, 2019 Pro Pro Pro
Feb 28, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 64.17B
AbbVie 56.33B
AstraZeneca 54.07B
Novartis AG 51.72B
Eli Lilly and Company 45.04B
Thermo Fisher Scientific 42.88B
Revenue Rankings

ACCD News

More News